Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Sino Biopharmaceutical Limited    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED (1177)
Add to my list  
My previous session
Most popular
Manage my lists
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
12/10/2018 12/11/2018 12/12/2018 12/13/2018 12/14/2018 Date
5.29 5.42 5.39 5.47 5.21 Last
118983640 92173270 68481690 51776987 65830263 Volume
-1.67% +2.46% -0.55% +1.48% -4.75% Change
Financials (CNY)
Sales 2018 20 484 M
EBIT 2018 5 364 M
Net income 2018 2 874 M
Finance 2018 1 841 M
Yield 2018 1,05%
Sales 2019 24 142 M
EBIT 2019 6 364 M
Net income 2019 3 370 M
Finance 2019 5 273 M
Yield 2019 1,26%
P/E ratio 2018 19,70
P/E ratio 2019 17,02
EV / Sales2018 2,75x
EV / Sales2019 2,19x
Capitalization 58 192 M
More Financials
Company
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of... 
Read more
Sector
Pharmaceuticals
Calendar
03/27Earnings Release
More about the company
Surperformance© ratings of Sino Biopharmaceutical Lim
Trading Rating : Investor Rating :
More Ratings
Latest news on SINO BIOPHARMACEUTICAL LIM
12/11SINO BIOPHARMACEUTICAL : gets painkiller approval
AQ
12/10SINO BIOPHARMACEUTICAL : Biopharm & director buy back company shares
AQ
12/05SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for interim dividend
FA
11/26SINO BIOPHARMACEUTICAL : Announces 2018 Third Quarterly Results
AQ
11/19SINO BIOPHARMACEUTICAL LIMITED : quaterly earnings release
09/13ASIA MARKETS: Asian Stock Markets Recover, Led By Japan And Hong Kong
DJ
09/13China biopharma stocks fall after centralized tendering talks
AQ
09/12ASIA MARKETS: Asian Markets Extend Slump As Hong Kong Stocks Sink Toward New ..
DJ
09/11SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for interim dividend
FA
08/27Hong Kong companies and directors step up buying of own shares as market weak..
AQ
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIM
More recommendations
Sector news : Pharmaceuticals - NEC
10:35aChina's Junshi Biosciences raises $394 million after pricing IPO at bottom of..
RE
09:42aMalaysia's IHH Healthcare halts open offer for India's Fortis after court rul..
RE
07:48aTAISHO PHARMACEUTICAL : said to near $1.6 billion deal for Bristol-Myers's UPSA-..
RE
07:35aNicox teams up with Chinese firm to develop and sell glaucoma drug
RE
06:12aTAISHO SAID TO NEAR $1.6 BILLION DEA : Bloomberg
RE
More sector news : Pharmaceuticals - NEC
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO BIOPHARMACEUTICAL LIM
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 8,06  CNY
Spread / Average Target 75%
EPS Revisions
Managers
NameTitle
Ping Tse Chief Executive Officer & Executive Director
Y Y Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Hsin Tse Executive Director & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
SINO BIOPHARMACEUTICAL LIMITED-62.68%8 398
JOHNSON & JOHNSON-4.81%356 703
PFIZER20.93%254 040
NOVARTIS5.61%223 295
ROCHE HOLDING LTD.1.38%216 307
MERCK AND COMPANY35.92%198 877
MarketScreener.com :
About :
Stay Connected :
Partners :
Copyright © 2018 Surperformance. All rights reserved.